| Q50457802 | A novel microfluidic approach for preparing chitosan-silica core-shell hybrid microspheres with controlled structures and their catalytic performance. |
| Q64057253 | A perspective on magnetic core-shell carriers for responsive and targeted drug delivery systems |
| Q30855722 | Acidic pH-targeted chitosan capped mesoporous silica coated gold nanorods facilitate detection of pancreatic tumors via multispectral optoacoustic tomography |
| Q38827516 | Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release |
| Q38271137 | Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. |
| Q34447152 | Application of chitosan-based nanocarriers in tumor-targeted drug delivery. |
| Q92353622 | Bioceramics: from bone substitutes to nanoparticles for drug delivery |
| Q55425710 | Biodegradable Alginate-Chitosan Hollow Nanospheres for Codelivery of Doxorubicin and Paclitaxel for the Effect of Human Lung Cancer A549 Cells. |
| Q45215886 | Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release |
| Q38189091 | Classification of stimuli-responsive polymers as anticancer drug delivery systems. |
| Q51786456 | Coaxial nanotubes of stimuli responsive polymers with tunable release kinetics. |
| Q55658954 | Core–Shell Nanoparticles as an Efficient, Sustained, and Triggered Drug-Delivery System. |
| Q30362001 | Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. |
| Q64999054 | Daylight Bactericidal Titania Textiles: A Contribution to Nosocomial Infections Control. |
| Q57186392 | Design strategies for chemical-stimuli-responsive programmable nanotherapeutics |
| Q39036109 | Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs |
| Q47795913 | Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications. |
| Q38298450 | General Strategy to Introduce pH-Induced Allostery in DNA-Based Receptors to Achieve Controlled Release of Ligands. |
| Q47324818 | Lectin-gated and glycan functionalized mesoporous silica nanocontainers for targeting cancer cells overexpressing Lewis X antigen. |
| Q50163907 | Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights. |
| Q88601057 | Mesoporous silica nanoparticles in nanomedicine applications |
| Q37989408 | Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery |
| Q57342490 | Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery |
| Q41006286 | Microfabrication for Drug Delivery |
| Q36201759 | NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy |
| Q57369291 | NIR-laser-triggered smart full-polymer nanogels for synergic photothermal-/chemo-therapy of tumors |
| Q50226322 | Nanoassemblies constructed from bimodal mesoporous silica nanoparticles and surface-coated multilayer pH-responsive polymer for controlled delivery of ibuprofen |
| Q42361372 | Nanotoxicology and Metalloestrogens: Possible Involvement in Breast Cancer |
| Q37131939 | Nonporous Silica Nanoparticles for Nanomedicine Application. |
| Q89909852 | Novel technique of insulin loading into porous carriers for oral delivery |
| Q39043619 | Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone. |
| Q39058091 | Plasma stable, pH-sensitive non-ionic surfactant vesicles simultaneously enhance antiproliferative effect and selectivity of Sirolimus |
| Q51036440 | Preparation, characterization, and DNA interaction studies of cationic europium luminescent copolymer. |
| Q36521096 | Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. |
| Q38854877 | Revisiting the 'One Material Fits All' Rule for Cancer Nanotherapy. |
| Q37638621 | Smart Mesoporous Nanomaterials for Antitumor Therapy. |
| Q38221776 | Smart chemistry in polymeric nanomedicine. |
| Q38154805 | Stimuli-responsive nanocarriers for drug delivery. |
| Q38032480 | Stimulus-responsive nanopreparations for tumor targeting |
| Q38567353 | Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors |
| Q64251593 | Strontium Sulfite: A New pH-Responsive Inorganic Nanocarrier to Deliver Therapeutic siRNAs to Cancer Cells |
| Q46196344 | Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. |
| Q31161857 | The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier |
| Q89002951 | The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells |
| Q35895231 | Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide. |
| Q59113319 | Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies |
| Q59133567 | Tumor Microenvironment Targeted Nanotherapy |
| Q38695106 | pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. |
| Q36422796 | pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release |
| Q34061003 | pH-titratable superparamagnetic iron oxide for improved nanoparticle accumulation in acidic tumor microenvironments |